← Browse by Condition
Medical Condition
non muscle invasive bladder cancer
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2, Phase 1, Phase 1, Phase 2
NCT06245603
Recruiting
A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer
Enrollment
200 pts
Location
Italy
Sponsor
Istituto Oncologico Veneto IRC...
NCT07036731
Recruiting
A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing
Enrollment
428 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT06663137 Phase 2
Recruiting
Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC
Enrollment
70 pts
Location
Israel
Sponsor
Relmada Therapeutics, Inc.
NCT05957757 Phase 2
Recruiting
RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression
Enrollment
20 pts
Location
China
Sponsor
RenJi Hospital
NCT06632964 Phase 1
Recruiting
A Clinical Trial Aimed At Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer
Enrollment
16 pts
Location
China
Sponsor
The Affiliated Hospital of Xuz...
NCT05790850
Recruiting
Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)
Enrollment
30 pts
Location
United States
Sponsor
University of Virginia
NCT06637423 Phase 1, Phase 2
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Enrollment
32 pts
Location
United States, Canad...
Sponsor
Merck Sharp & Dohme LLC
NCT05825950
Recruiting
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
Enrollment
600 pts
Location
United States
Sponsor
University of Texas Southweste...